© 2026 Sinochem Nanjing Corporation,
All Right Reserved
|
HS Code |
656764 |
As an accredited N,N-Dimethyl-4-Bromobenzenesulfonamide factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive N,N-Dimethyl-4-Bromobenzenesulfonamide prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
N,N-Dimethyl-4-Bromobenzenesulfonamide isn’t a mouthful just for show—this compound draws attention for a reason. Scientists and chemists who’ve spent time in research labs or hands-on in manufacturing can spot its value fast. The structure—a bromine atom at the para position paired with a bulky sulfonamide group—makes this molecule stand out in organic synthesis. It’s more than a shelf stock; it helps drive reactions that standard sulfonamides can’t always pull off reliably.
Years in the lab showed me the impact that little structural tweaks in molecules have on making new compounds possible. Adding the dimethyl and bromine elements opens doors. For researchers chasing selectivity in reactions or requiring intermediates with unique electron-withdrawing properties, this compound quickly finds a place in their toolkit. Most generic sulfonamides don’t cut it when high specificity is needed or when the end product hinges on blocking unwanted side reactions. That’s where this tailored molecule fits in.
This type of sulfonamide often comes as a white or off-white crystalline powder, recognizable to those familiar with advanced starting materials. Consistently high purity is the baseline in the industry, usually topping 98%. A product that lowballs on quality risks introducing impurities to pharmaceutical projects or chemical experiments—a headache for anyone who’s spent days troubleshooting reactions because of a single contaminated reagent.
A melting point between 120 and 125 degrees Celsius separates genuine material from off-spec lots. Experience tells me that even a couple of degrees off from the spec means running the lot through another round of purification or skipping to a new supplier altogether. Sticking to batch-certified products minimizes headaches downstream. In my previous work with medicinal chemistry teams, this reduced failed syntheses and helped nail timelines.
Working with N,N-Dimethyl-4-Bromobenzenesulfonamide, I’ve seen its influence stretch beyond textbooks. Its biggest value emerges in laboratories focused on building complex organic molecules or crafting new drug candidates. Medicinal and process chemists reach for this compound when they need stable intermediates that can handle tough reaction conditions. The dimethylsulfonamide group resists easy decomposition, so reactions run cleaner—especially in the choppy waters of multi-step synthesis.
For reaction steps that join aromatic rings or add unusual functional groups, the bromine atom is a reliable handle. It doesn’t react unpredictably, so it’s perfect for Suzuki and Buchwald-Hartwig cross-couplings, two workhorse reactions in organic and pharmaceutical chemistry. Years ago, I watched a team shave days off a campaign just by switching to this brominated intermediate for their coupling reaction. That sort of efficiency boost doesn’t often come from the more basic sulfonamide family.
Some folks assume all sulfonamides do the same job, but experience shows big differences emerge fast. N,N-Dimethyl-4-Bromobenzenesulfonamide differs by design—especially the para-bromo group—making it essential for chemists trying to avoid excess byproducts or seeking a site-specific transformation. While standards like p-toluenesulfonamide or benzenesulfonamide find regular use, their lack of tailored substituents can limit selectivity, leading researchers to juggle cleanup steps or navigate unpredictable yields.
The switch to the dimethyl variant, especially with bromine on the ring, often pays off with better yields, fewer purification runs, and less lingering frustration at the bench. After a round of optimization, process chemists usually don’t go back. The structure allows for direct engagement in palladium-catalyzed reactions, making it valuable in setting up aryl-amine or aryl-aryl bonds that sit at the heart of active pharmaceutical ingredients.
Trust counts for a lot in science—a lesson that sticks after spending late nights troubleshooting reaction fails. Sources who’ve consistently supplied high-quality N,N-Dimethyl-4-Bromobenzenesulfonamide earned their keep by ensuring tight quality controls, documented specs, and reliable COAs. Without this level of transparency, chemists face more than just lost time; a tainted intermediate can domino into regulatory chaos for those working in drug pipelines.
The track record for products like this often comes from long-standing feedback cycles between end-users and suppliers. A batch that performs as promised keeps research and manufacturing lines moving smoothly. One poor result, and the trust evaporates. In my work sourcing reagents, I saw the value of sticking with vendors who weren’t afraid to answer hard questions about lot numbers, analytic methods, and consistency across shipments. The same care applies to this compound, since it plays a decisive role in both benchtop research and scaled-up manufacturing.
Handling brominated compounds brings its own set of challenges—ones that anybody who’s spent time around fine chemicals understands well. Although N,N-Dimethyl-4-Bromobenzenesulfonamide is no more hazardous on paper than many specialty chemicals, taking basic precautions remains smart practice. This means working under fume hoods, using gloves, and labeling all containers clearly. Even seasoned chemists double-check protocols when dealing with sulfonamides and especially brominated reagents, since trace volatility and dust can carry risk.
On the waste side, brominated products need careful attention during disposal. While not as environmentally persistent as some halogenated aromatics, they shouldn’t get lumped in with non-halogenated laboratory waste. Facilities following best practices prefer validated disposal partners for such chemicals. Having seen the impact of poor chemical management at university facilities early in my career, sticking with structured protocols and up-to-date safety data pays dividends—not just for compliance, but for everyone in the building.
For research labs building new drugs, polymers, or specialty chemicals, having reliable advanced intermediates is crucial. N,N-Dimethyl-4-Bromobenzenesulfonamide helps close that gap by serving as a stepping stone in routes that involve numerous transformations. The compound’s uniqueness becomes particularly clear when multi-step syntheses face bottlenecks—such as hard-to-install functionalities, low intermediate yields, or troublesome impurity profiles.
Even with automation and high-throughput screening, chemists continue to demand responsive reagents. In practice, the less time spent purifying crude intermediates, the more likely timelines get met. I recall projects in which the switch to a brominated dimethylsulfonamide led not only to better isolated yields, but also to a remarkable reduction in side-product formation—results that justified the cost difference several times over, especially in pharma applications with steep cost-of-delay curves.
Moving from academic projects into regulated industry work underscored a lesson: It’s not enough to just buy reagents; you need to be able to trace them back to the source, batch, and even the analytic workup. Documentation around advanced intermediates like N,N-Dimethyl-4-Bromobenzenesulfonamide makes all the difference in passing audits or preparing regulatory filings for new therapies.
Establishing that the supplier provides detailed COAs and batch analytics gives confidence that the compound fits cGMP conditions or other regulatory frameworks when needed. Not every advanced chemical hits these marks, especially from smaller producers. In my years paired with QA colleagues, sending a certificate with every lot, plus documented analytical methods, made more difference to project peace-of-mind than any marketing language. The most reliable intermediates always come from suppliers who welcome due diligence from their customers.
Recent global supply uncertainties spotlighted the value of stable access to specialty chemicals. With N,N-Dimethyl-4-Bromobenzenesulfonamide, unpredictability often arrives from swings in precursor availability or transport disruptions. In the worst cases, chemists see work grind to a halt as they scramble for alternate suppliers or adapt to new impurity profiles in off-brand material. Lessons from earlier disruptions point to a few key solutions.
Strong supplier relationships and clear forward planning make the difference. Rather than running to the cheapest source, seasoned labs keep trusted vendors looped in, place advanced orders, and work with inventory controls that flag low stock early. Manufacturing teams benefit from secondary suppliers pre-approved against documented standards. Over time, such careful management paid off by keeping projects on schedule and avoiding costly switchovers in protocol or troubleshooting.
Sustainability draws increasing focus for all fine chemicals, and brominated reagents are no exception. Newer synthesis routes for N,N-Dimethyl-4-Bromobenzenesulfonamide leverage milder reagents and minimize hazardous byproducts. In academic and commercial settings, shifting to greener methods—such as using water as a solvent or sourcing sustainable brominating agents—slowly gains ground without sacrificing performance.
Looking at greener routes over the years, I’ve noticed that incremental improvement works best. Each new process revision ratchets down waste volumes or selects catalytic systems that run with less energy input. Even if the classic manufacturing processes remain industry staples, demand grows for products that report lower overall environmental impacts, both upstream and downstream. As regulations tighten, these process improvements become a selling point—one matched by the growing number of researchers who care about the full lifecycle of their materials.
Those stepping into advanced organic synthesis for the first time often underestimate the difference a single substituent makes. N,N-Dimethyl-4-Bromobenzenesulfonamide rewards those who read up on its reactivity and handling guidelines in advance. For academic groups on tight budgets, sharing best practices and even sample swaps can help avoid wasted time on cumbersome purification steps. Quality of life at the fume hood rises fast when using intermediates that cut down on post-reaction cleanups and reduce frustration.
Mentoring undergraduates and new postdocs on using specialized intermediates, I found that hands-on walkthroughs—setting up cross-coupling runs, purifying with simple recrystallization, confirming structure with routine NMR—make the real difference. Textbooks can’t replace what’s learned from a week at the bench, but a product that’s been through these tests makes learning smoother and disappointment less frequent.
As research shifts toward complex targets, demand for robust intermediates grows. N,N-Dimethyl-4-Bromobenzenesulfonamide acts as a workhorse for diverse projects, playing a silent but key role in exploring new medicinal scaffolds or advanced materials. In my experience, projects that kept a well-chosen set of intermediates on hand were able to pivot faster, respond to unexpected results, and make more inventive leaps. The importance of a compound like this rises with each round of synthetic problem-solving, ensuring that no promising lead gets shelved because of material limitations.
Even as automation, AI-driven screening, and microfluidic platforms reshape how chemists work, demand for consistent, performance-driven reagents only grows. Product managers and scientists who stay close to the bench keep a mental map of which reagents consistently deliver—N,N-Dimethyl-4-Bromobenzenesulfonamide steadily climbs that list in advanced organic synthesis settings.
I’ve argued with more than one purchasing manager about why a slightly more expensive intermediate still pays its way. The real value of N,N-Dimethyl-4-Bromobenzenesulfonamide shows itself through saved hours, better reproducibility, and easier troubleshooting. Projects faltered more from an unreliable supply or unexpected impurities than from the list price of a quality intermediate. For organizations understood this, procurement focused less on price and more on reliability and overall project cost.
In industrial settings, each hour lost to rework or an off-spec batch racks up quickly. Engineers and synthetic chemists who manage timelines fight for reagents that work right the first time. Having dealt with both shoestring budgets and well-supported projects, my take remains the same—a few dollars more for predictable performance beats days lost to cleanups or troubleshooting.
There’s another legacy to compounds like N,N-Dimethyl-4-Bromobenzenesulfonamide—they help train the next wave of chemists. Access to specialized and robust reagents means students get exposed to the kinds of complex syntheses they’ll face in post-grad and industrial labs. Sharing best practices on storage, handling, and reactivity builds habits that serve a lifetime.
Programs that support academic-industry partnerships often choose intermediates like this precisely because they represent real-world materials rather than diluted teaching samples. Watching students succeed at previously daunting multi-step syntheses because the right intermediate made things work always feels like an investment paying off.
As research targets sharpen and regulatory scrutiny rises, every step in the synthetic chain matters. N,N-Dimethyl-4-Bromobenzenesulfonamide answers a practical need in both industry and research—a reliable, high-purity intermediate with tailored properties that support efficient, high-yielding reactions. The real-world lessons learned in handling, sourcing, and applying this compound carry over to each new generation of chemicals that shape tomorrow’s medicines and materials.
Chemists and engineers who prioritize trusted sources, regulatory support, and ongoing learning will find intermediates like this continue to anchor progress. For those who value rigorous science without unnecessary complications, N,N-Dimethyl-4-Bromobenzenesulfonamide stands as a model of how incremental improvements in reagents pay back in more successful projects, stronger teams, and better results for everyone invested in chemical innovation.
